SCHEMBL19813081

SCHEMBL19813081

Cc1ccccc1C(=O)NC(CO)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.56
LMNA P02545 2/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.56
HSD17B10 Q99714 1/20 0.56
UTS2R Q9UKP6 1/20 0.55
RIPK1 Q13546 1/20 0.52
TACR3 P29371 1/20 0.52
MAPK1 P28482 3/20 0.51
PAK4 O96013 2/20 0.51
MAPK13 O15264 1/20 0.51
ROCK2 O75116 1/20 0.51
RPS6KA5 O75582 1/20 0.51
MAP4K4 O95819 1/20 0.51
PRKCG P05129 1/20 0.51
CDK1 P06493 1/20 0.51
PRKACA P17612 1/20 0.51
RPS6KB1 P23443 1/20 0.51
CDK2 P24941 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16679895 0.83 L3MBTL1 (0.53) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL16679897 0.83 L3MBTL1 (0.53) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL5643849 0.81 NPC1 (0.55) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL28015856 0.81 ALDH1A1 (0.60) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL30776214 0.81 HPGD (0.68) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL28693505 0.80 HPGD (0.56) HPGDLMNAKDM4EALDH1A1HSD17B10
SCHEMBL8855769 0.80 KDM4E (0.51) HPGDLMNAKDM4EALDH1A1TSHR
SCHEMBL3311541 0.79 RIPK1 (0.60) ALDH1A1RIPK1TACR3MAPK1PAK4
SCHEMBL668277 0.79 RIPK1 (0.60) ALDH1A1RIPK1TACR3MAPK1PAK4
SCHEMBL117597 0.79 RIPK1 (0.60) ALDH1A1RIPK1TACR3MAPK1PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10188649-B2 Aminoheteroaryl benzamides as kinase inhibitors NOVARTIS AG (CH) 2019-01-29 US disclosed
US-20180028532-A1 AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS NOVARTIS AG (CH) 2018-02-01 US disclosed
CN-104529796-A Catalytic synthesis application based on frustrated Lewis acid-base pair UNIV HUNAN 2015-04-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10188649-B2 Aminoheteroaryl benzamides as kinase inhibitors ABL1, MAP3K12, MAP3K2 HPGD 3257/4885LMNA 4403/4885KDM4E 657/4885
US-20180028532-A1 AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS ABL1, MAP3K12, MAP3K2 HPGD 3257/4885LMNA 4403/4885KDM4E 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.